Tenvie Therapeutics is committed to transforming the treatment of neurological diseases by leveraging a deep and diverse portfolio of small molecule assets, including programs acquired from Denali Therapeutics Inc., supported by a proven team of research and development leaders.
Market
Neurological diseases
Location
South San Francisco,
California,
USA
Coinvestors
ARCH Venture Partners, F-Prime Capital, Mubadala Capital